📰 Lidds Ab News
Lidds Ab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lidds Ab. Real-time updates on events, politics, business and more.
February 24, 2022
Investegate announcements from LIDDS AB, Statement from LIDDS regarding convertible note agreement
February 23, 2022
Investegate announcements from LIDDS AB, LIDDS AB (publ) Year-end report 2021
February 22, 2022
Investegate announcements from LIDDS AB, LIDDS secures financing of up to 40.8 MSEK to create foundation for new partnerships based on the NanoZolid® technology
February 21, 2022
Investegate announcements from LIDDS AB, LIDDS Next Step with NanoZolid® formulated docetaxel
January 14, 2022
Investegate announcements from LIDDS AB, LIDDS presents at Redeye Fight Cancer Seminar
January 11, 2022
Investegate announcements from LIDDS AB, LIDDS announces successful stage 1 in R&D project
December 29, 2021
Investegate announcements from LIDDS AB, LIDDS announces positive topline results from the phase I dose-escalating study of NanoZolid®-formulated docetaxel
December 17, 2021
Investegate announcements from LIDDS AB, LIDDS patent covering the NanoZolid® production process granted in China
October 4, 2021
Investegate announcements from LIDDS AB, NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy
February 24, 2021
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid® for treatment of brain cancers was filed to the European...